In a statement issued on Wednesday December 28, 2016 Janney Capital raised the target price of Impax Labs …
NASDAQ
Impax Laboratories Inc. (NASDAQ:IPXL)‘s stock had its “hold” rating restated by equities researchers at Deutsche Bank AG in a research report issued to clients and investors on Friday. They currently have a …
BNS23d
Deutsche Bank
The stock has a market cap of $88.09 billion ... the authorized generic for Adrenaclick® manufactured by Impax Laboratories (IPXL), is available at all CVS Pharmacy locations at a cash price of $109.99 for a two-pack. …
CVS Health Corporation
Six equities research analysts have rated the stock with a hold rating and thirteen have assigned ... the authorized generic for Adrenaclick® manufactured by Impax Laboratories (IPXL), is available at all CVS Pharmacy …
CVS Health Corporation
Allergan Inc (AGN): AGN stock is up 2.1% today ... Article printed from InvestorPlace Media, http://investorplace.com/2014/10/biggest-movers-in-healthcare-stocks-now-ipxl-agn-wst-icui-ipxl-agn-wst/.
Sign-up for a FREE trial here. (Reuters) - Drugstore chain CVS Health Corp (NYSE: CVS) has started selling a generic version of Impax …
CVS
Skandinaviska Enskilda Banken AB publ raised its stake in shares of Impax Laboratories, Inc. (NASDAQ:IPXL) by 17.1% during the third quarter, Holdings Channel reports. The fund owned 206,400 shares of the specialty …
Skandinaviska Enskilda Banken
On Wednesday the company's stock fell 4.3%. Meanwhile ... instead encouraging patients to use Impax's IPXL generic device for treatment …
MSN7h
EpiPen Empire